JMJD5-RCCD1 Complex Drives Platinum Resistance in Non-Small Cell Lung Cancer
A study in Molecular Biomedicine reveals that the JMJD5-RCCD1 complex promotes platinum resistance in NSCLC by driving FN1-mediated epithelial–mesenchymal transition ...
A study in Molecular Biomedicine reveals that the JMJD5-RCCD1 complex promotes platinum resistance in NSCLC by driving FN1-mediated epithelial–mesenchymal transition ...
A comparative study of 35 health technology appraisals found a 56.3% concordance in cost-effectiveness conclusions for lung cancer immunotherapies between ...
A machine learning model developed at Huazhong University of Science and Technology can non-invasively predict the high-risk PD-L1+ CD8- immune ...
A study combining computational modeling and cell experiments shows galangin reduces non-small cell lung cancer cell growth and invasion by ...
Researchers have developed a novel class of ligand-engineered biomimetic nanoparticles designed to target the adhesion G protein-coupled receptor F5 (ADGRF5) ...
A retrospective study reveals that comprehensive genomic profiling identifies more actionable genetic alterations in patients with advanced solid tumors compared ...
A review in Genes & Diseases highlights how evaluating tumor genetics alongside the surrounding immune microenvironment can refine immunotherapy selection ...
A study in the Journal of Cardiothoracic Surgery identifies miR-450a-5p as an oncogenic driver in non-small cell lung cancer that ...
Serial biopsies in an ALK-positive lung cancer patient reveal the complexities of monitoring molecular evolution and the risks of relying ...
Hyperthermia enhances anti-PD-L1 immunotherapy efficacy in preclinical non-small cell lung cancer models by upregulating PD-L1 expression through activation of the ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine